S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 94.9 TWD -1.15% Market Closed
Market Cap: 11.3B TWD
Have any thoughts about
SCI Pharmtech Inc?
Write Note

SCI Pharmtech Inc
Accounts Payable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

SCI Pharmtech Inc
Accounts Payable Peer Comparison

Comparables:
Y
3705
4746
1789
1795
1720

Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors

Company Accounts Payable CAGR 3Y CAGR 5Y CAGR 10Y
S
SCI Pharmtech Inc
TWSE:4119
Accounts Payable
NT$51.9m
CAGR 3-Years
23%
CAGR 5-Years
-13%
CAGR 10-Years
-7%
Y
YungShin Global Holding Corp
TWSE:3705
Accounts Payable
NT$598.7m
CAGR 3-Years
2%
CAGR 5-Years
0%
CAGR 10-Years
8%
Formosa Laboratories Inc
TWSE:4746
Accounts Payable
NT$228.4m
CAGR 3-Years
27%
CAGR 5-Years
16%
CAGR 10-Years
6%
ScinoPharm Taiwan Ltd
TWSE:1789
Accounts Payable
NT$149.4m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
-4%
Lotus Pharmaceutical Co Ltd
TWSE:1795
Accounts Payable
NT$696.9m
CAGR 3-Years
-16%
CAGR 5-Years
-20%
CAGR 10-Years
11%
Standard Chem & Pharm Co Ltd
TWSE:1720
Accounts Payable
NT$607.3m
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
6%

See Also

What is SCI Pharmtech Inc's Accounts Payable?
Accounts Payable
51.9m TWD

Based on the financial report for Jun 30, 2024, SCI Pharmtech Inc's Accounts Payable amounts to 51.9m TWD.

What is SCI Pharmtech Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
-7%

Over the last year, the Accounts Payable growth was 41%. The average annual Accounts Payable growth rates for SCI Pharmtech Inc have been 23% over the past three years , -13% over the past five years , and -7% over the past ten years .

Back to Top